Bionor Pharmas studie av HIV-vaksine med nasal administrasjon - alle pasienter er fullt innrullert

Oslo 04.01.2012 - Bionor Pharma studerer «nasal administrasjon» (nesedråper) av selskapets terapeutiske HIV vaksine Vacc-4x i kombinasjon med Eurocine Vaccine’s Endocine™. Alle pasienter er nå innrullert. En ny alternativ behandlingsform vil kunne gi lettere tilgang til behandling for HIV-positive globalt.

Read more about Bionor Pharmas studie av HIV-vaksine med nasal administrasjon - alle pasienter er fullt innrullert

Invitation to Annual General Meeting 27.05.2011

Oslo, 06.05.2011 - The Annual General Meeting of Bionor Pharma ASA will be held on Friday 27 May 2011, 10:00 a.m. at Hotel Continental in Oslo.

Read more about Invitation to Annual General Meeting 27.05.2011

Bionor Pharma appoints Vice President Business Development

Oslo, 19.05.2011. Bionor Pharma ASA has today appointed Frode Hellesnes as Vice President for Business Development.

Read more about Bionor Pharma appoints Vice President Business Development

Erik Danielsen nominated as new board member

Oslo, 23.05.2011 - Erik Danielsen is nominated as new board member in Bionor Pharma ASA.

Read more about Erik Danielsen nominated as new board member

Minutes from the Annual General Meeting of Bionor Pharma ASA

27.05.2011 - Bionor Pharma ASA´s Annual General Meeting was held today. All proposed resolutions in the notice to the meeting were approved by the shareholders

Read more about Minutes from the Annual General Meeting of Bionor Pharma ASA

New Board of Directors elected in Bionor Pharma ASA

Oslo, 25.07.2011 - The shareholders of Bionor Pharma ASA today elected a new Board of Directors at the Extraordinary General Meeting.

Read more about New Board of Directors elected in Bionor Pharma ASA

Henrik Lund fratrer som CEO i Bionor Pharma ASA

Oslo, 15.08.2011 - Styret i Bionor Pharma ASA har kommet til enighet medCEO Henrik Lund om avslutning av arbeidsforholdet.

Read more about Henrik Lund fratrer som CEO i Bionor Pharma ASA

Industry Specialist Steen Krøyer is the new CEO

Oslo, 05.09.2011 - Steen Krøyer appointed as interim CEO of Bionor Pharma ASA

Read more about Industry Specialist Steen Krøyer is the new CEO

Bransjespesialist Steen Krøyer ny adm. dir.

Oslo, 05.09.2011 - Steen Krøyer tiltrer som ny adm. dir. i Bionor Pharma ASA

Read more about Bransjespesialist Steen Krøyer ny adm. dir.

Adm. dir. tildelt opsjonsordning

20.10.2011 - Adm. dir. Steen Krøyer i Bionor Pharma tildelt opsjonsordning

Read more about Adm. dir. tildelt opsjonsordning

Mandatory notification of trade

Oslo, 04.10.2011 - CEO of Bionor Pharma ASA, Steen Krøyer, has today purchased 100,000 shares

Read more about Mandatory notification of trade

Mandatory notification of trade

Oslo, 04.10.2011 - Board member of Bionor Pharma ASA, Marianne Furru, has today purchased 140,000 shares

Read more about Mandatory notification of trade

Flagging - fullmakter til ekstraordinær generalforsamling

Oslo, 21.07.2011 - Erik Danielsen mottatt fullmakter for 43,54 % av selskapets aksjer og stemmer

Read more about Flagging - fullmakter til ekstraordinær generalforsamling

Invitation to the Extraordinary General Meeting 25.07.2011

Oslo, 30.06.2011 - The Extraordinary General Meeting of Bionor Pharma ASA will be held on Monday 25 July 2011, 10:00 a.m. at Hotel Continental in Oslo.

Read more about Invitation to the Extraordinary General Meeting 25.07.2011